Bone marrow biopsy and aspiration: a departmental financial comparison in a rural hospital

Nancy W Bethuel1, Eric Bravin2, Nicole Krupa2

  • 1Bassett Medical Center, One Atwell Road, Cooperstown, NY, 13326, USA. nancy.bethuel@bassett.org.

BMC Research Notes
|March 5, 2021
PubMed

Insights

Interventional radiology specialists charged and were reimbursed significantly more for bone marrow procedures than hematology/oncology specialists. Specimen adequacy was similar between groups, though interventional radiology patients had higher BMIs.

Area of Science:

  • Oncology
  • Radiology
  • Health Economics

Background:

  • Bone marrow aspiration and biopsies are critical diagnostic procedures.
  • Specialty choice for these procedures can impact healthcare costs and resource utilization.
  • Understanding cost differences is vital for healthcare management, especially in rural settings.

Purpose of the Study:

  • To compare hospital charges and payments for bone marrow aspiration and biopsies performed by interventional radiology (IR) versus hematology/oncology (H/O) specialists.
  • To assess specimen quality and the association of body mass index (BMI) with specialist choice.

Main Methods:

  • Retrospective analysis of bone marrow aspiration and biopsy procedures at Bassett Medical Center.
  • Comparison of charges, payments, and specimen adequacy between IR and H/O groups.
  • Statistical analysis to determine differences in costs, sample quality, and patient demographics (including BMI).

Main Results:

  • Interventional radiology procedures incurred significantly higher median charges ($5254) and payments ($1392) compared to hematology/oncology procedures ($413 and $1109, respectively).
  • Specimen adequacy was comparable between the two specialist groups.
  • Patients undergoing procedures with interventional radiology specialists had a significantly higher mean BMI (34.3) than those seen by hematology/oncology specialists (28.6).

Conclusions:

  • Interventional radiology specialists perform bone marrow procedures at a substantially higher cost to the hospital compared to hematology/oncology specialists.
  • Despite cost differences, specimen quality is not compromised.
  • Higher BMI in patients undergoing IR procedures may warrant further investigation into its role in specialist selection and procedural outcomes.
Abstract